New drug tested for rare, spreading eye cancer
NCT ID NCT00244816
Summary
This study tested a weekly chemotherapy drug called Taxoprexin in patients whose eye melanoma had spread to other parts of the body. The main goal was to see if the drug could shrink tumors and how long patients lived. It involved 22 participants who received the drug by IV infusion until their cancer worsened or side effects became too severe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030-4009, United States
Conditions
Explore the condition pages connected to this study.